IBD Patients Willing to Accept High Medication Risks to Maintain Disease Remission

IBD Patients Willing to Accept High Medication Risks to Maintain Disease Remission
According to the results of a recent survey study published in The American Journal of Gastroenterology, patients with inflammatory bowel disease (IBD) reported they were willing to accept the fairly high risks of lymphoma and serious infections related with medical therapies to maintain remission and avoid disease relapse. The study is titled “Inflammatory Bowel Disease

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *